Variable (n) | Overall survival | ||
---|---|---|---|
Hazard ratio (95% CI) | P value univariable | P value multivariable | |
Age | 1.00 (0.98–1.02) | 0.97 |  |
  ≥ 70 (41) versus < 70 (36) | 0.77 (0.45–1.30) | 0.32 |  |
Sex | |||
 Male (27) versus female (50) | 2.26 (1.31–3.90) |  < 0.01 | n.s |
CCI | |||
  > 4 (38) versus ≤ 4 (39) | 2.02 (1.17–3.45) | 0.01 | n.s |
Dose in Gy | |||
  ≥ 39 (47) versus < 39 (30) | 0.63 (0.37–1.07) | 0.09 |  |
Transfusion(s) necessary | |||
 Yes (30) versus No (47) | 1.20 (0.70–2.07) | 0.51 |  |
Bleeding as first sign of disease | |||
 Yes (32) versus No (45) | 0.66 (0.38–1.13) | 0.13 |  |
Systemic therapy | |||
 Yes (30) versus No (47) | 0.88 (0.51–1.52) | 0.64 |  |
Acute organ toxicity | |||
 Yes (35) versus No (42) | 0.69 (0.41–1.19) | 0.18 |  |
Localization pelvis versus other | |||
 Yes (46) versus No (31) | 0.54 (0.32–0.93) | 0.03 | n.s |
Therapy completed as intended | |||
 No (14) versus Yes (63) | 4.27 (2.07–8.78) |  < 0.01 |  < 0.001 |
Radiotherapy techniquea | |||
 Dynamic (17) versus conventional (55) | 0.63 (0.33–1.21) | 1.66 |  |
Primary site | |||
 CC/ENC (29) versus others (48) | 0.29 (0.16–0.54) |  < 0.01 |  < 0.001 |